HOUSTON--(BUSINESS WIRE)--Power3 Medical Products, Inc. (OTCBB: PWRM), a leading proteomics company specializing in the development and commercialization of diagnostic tests for the early detection of breast cancer and neurodegenerative diseases, has filed two Utility Patent Applications with the U.S. Patent and Trademark Office. The two patents are for a number of the Company’s identified blood serum protein biomarkers, part of Power3’s clinically validated biomarker panel for early detection and differential diagnosis of Parkinson’s disease.
